NorthStar Asset Management (Pennsylvania)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.51M | Sell |
17,307
-1,099
| -6% | -$596K | 1.91% | 11 |
|
|
2025
Q4 | $10.7M | Sell |
18,406
-384
| -2% | -$217K | 2.26% | 10 |
|
|
2025
Q3 | $9.11M | Sell |
18,790
-1,498
| -7% | -$697K | 1.96% | 11 |
|
|
2025
Q2 | $8.23M | Sell |
20,288
-1,093
| -5% | -$457K | 1.89% | 11 |
|
|
2025
Q1 | $10.6M | Sell |
21,381
-25
| -0.1% | -$13.5K | 2.57% | 8 |
|
|
2024
Q4 | $11.1M | Sell |
21,406
-65
| -0.3% | -$35.7K | 2.55% | 8 |
|
|
2024
Q3 | $13.3M | Sell |
21,471
-150
| -0.7% | -$88.8K | 3.04% | 7 |
|
|
2024
Q2 | $12M | Sell |
21,621
-85
| -0.4% | -$48.7K | 2.89% | 7 |
|
|
2024
Q1 | $12.6M | Buy |
21,706
+35
| +0.2% | +$19.6K | 3.11% | 7 |
|
|
2023
Q4 | $11.5M | Sell |
21,671
-496
| -2% | -$240K | 3.03% | 7 |
|
|
2023
Q3 | $11.2M | Buy |
22,167
+10
| +0% | +$5.33K | 3.23% | 6 |
|
|
2023
Q2 | $11.6M | Sell |
22,157
-100
| -0.4% | -$54K | 3.18% | 6 |
|
|
2023
Q1 | $12.8M | Sell |
22,257
-715
| -3% | -$403K | 3.77% | 5 |
|
|
2022
Q4 | $12.7M | Sell |
22,972
-15
| -0.1% | -$7.95K | 3.99% | 4 |
|
|
2022
Q3 | $11.7M | Buy |
22,987
+55
| +0.2% | +$30.8K | 3.89% | 5 |
|
|
2022
Q2 | $12.5M | Sell |
22,932
-425
| -2% | -$234K | 3.89% | 4 |
|
|
2022
Q1 | $13.8M | Sell |
23,357
-199
| -0.8% | -$114K | 3.53% | 5 |
|
|
2021
Q4 | $15.7M | Buy |
23,556
+50
| +0.2% | +$31.2K | 3.69% | 4 |
|
|
2021
Q3 | $13.4M | Buy |
23,506
+25
| +0.1% | +$13.7K | 3.52% | 5 |
|
|
2021
Q2 | $11.8M | Sell |
23,481
-410
| -2% | -$193K | 3.11% | 5 |
|
|
2021
Q1 | $10.9M | Sell |
23,891
-758
| -3% | -$362K | 3.1% | 5 |
|
|
2020
Q4 | $11.5M | Sell |
24,649
-1,507
| -6% | -$707K | 3.26% | 5 |
|
|
2020
Q3 | $11.5M | Sell |
26,156
-125
| -0.5% | -$51.6K | 3.69% | 3 |
|
|
2020
Q2 | $9.52M | Buy |
26,281
+75
| +0.3% | +$25.1K | 3.41% | 4 |
|
|
2020
Q1 | $7.43M | Sell |
26,206
-69
| -0.3% | -$21.8K | 3.4% | 5 |
|
|
2019
Q4 | $8.54M | Sell |
26,275
-2,747
| -9% | -$833K | 3.21% | 6 |
|
|
2019
Q3 | $8.45M | Buy |
29,022
+515
| +2% | +$147K | 3.29% | 6 |
|
|
2019
Q2 | $8.37M | Sell |
28,507
-834
| -3% | -$230K | 3.3% | 6 |
|
|
2019
Q1 | $8.03M | Sell |
29,341
-1,300
| -4% | -$324K | 3.27% | 7 |
|
|
2018
Q4 | $6.86M | Sell |
30,641
-276
| -0.9% | -$64.8K | 3.21% | 7 |
|
|
2018
Q3 | $7.55M | Sell |
30,917
-296
| -0.9% | -$68.1K | 2.93% | 7 |
|
|
2018
Q2 | $6.46M | Sell |
31,213
-696
| -2% | -$148K | 2.68% | 7 |
|
|
2018
Q1 | $6.59M | Sell |
31,909
-60
| -0.2% | -$12.6K | 2.77% | 6 |
|
|
2017
Q4 | $6.07M | Sell |
31,969
-1,301
| -4% | -$249K | 2.51% | 6 |
|
|
2017
Q3 | $6.29M | Sell |
33,270
-2,160
| -6% | -$391K | 2.76% | 6 |
|
|
2017
Q2 | $6.18M | Sell |
35,430
-930
| -3% | -$156K | 2.78% | 6 |
|
|
2017
Q1 | $5.58M | Sell |
36,360
-270
| -0.7% | -$41.3K | 2.49% | 8 |
|
|
2016
Q4 | $5.17M | Sell |
36,630
-9,825
| -21% | -$1.45M | 2.33% | 8 |
|
|
2016
Q3 | $7.39M | Sell |
46,455
-1,650
| -3% | -$254K | 3.09% | 6 |
|
|
2016
Q2 | $7.11M | Sell |
48,105
-554
| -1% | -$81.8K | 2.96% | 7 |
|
|
2016
Q1 | $6.89M | Sell |
48,659
-1,425
| -3% | -$191K | 2.94% | 7 |
|
|
2015
Q4 | $7.11M | Sell |
50,084
-1,198
| -2% | -$160K | 3.03% | 6 |
|
|
2015
Q3 | $6.27M | Sell |
51,282
-105
| -0.2% | -$13.7K | 2.81% | 8 |
|
|
2015
Q2 | $6.67M | Sell |
51,387
-325
| -0.6% | -$42.4K | 2.79% | 8 |
|
|
2015
Q1 | $6.95M | Sell |
51,712
-1,000
| -2% | -$129K | 2.98% | 7 |
|
|
2014
Q4 | $6.6M | Sell |
52,712
-3,688
| -7% | -$448K | 2.87% | 10 |
|
|
2014
Q3 | $6.86M | Buy |
56,400
+125
| +0.2% | +$15.2K | 2.98% | 8 |
|
|
2014
Q2 | $6.64M | Buy |
56,275
+1,000
| +2% | +$118K | 2.83% | 12 |
|
|
2014
Q1 | $6.65M | Sell |
55,275
-1,435
| -3% | -$171K | 3.05% | 9 |
|
|
2013
Q4 | $6.32M | Sell |
56,710
-475
| -0.8% | -$47.2K | 2.94% | 12 |
|
|
2013
Q3 | $5.27M | Sell |
57,185
-1,815
| -3% | -$164K | 2.69% | 14 |
|
|
2013
Q2 | $4.99M | Buy |
+59,000
| New | +$4.91M | 2.14% | 15 |
|
Other funds holding TMO
VCM
NorthStar Asset Management (Pennsylvania)'s TMO Position: Q1 2026 in Review
NorthStar Asset Management (Pennsylvania) reduced its Thermo Fisher Scientific (TMO) stake by 6% in Q1 2026, selling an estimated $596K and leaving 17,307 shares worth $8.51M. The position accounts for 1.91% of the portfolio, ranked #11.
NorthStar Asset Management (Pennsylvania) first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.7M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- NorthStar Asset Management (Pennsylvania) held 17,307 shares of Thermo Fisher Scientific worth $8.51M as of Q1 2026.
- NorthStar Asset Management (Pennsylvania) sold 1,099 Thermo Fisher Scientific shares in Q1 2026, an estimated $596K.
- Thermo Fisher Scientific made up 1.91% of NorthStar Asset Management (Pennsylvania)'s portfolio in Q1 2026, its #11 holding.
- NorthStar Asset Management (Pennsylvania) first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- NorthStar Asset Management (Pennsylvania)'s Thermo Fisher Scientific position peaked at $15.7M in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q1 2026, filed 23 Apr 2026.